Assessing muscle loss in lung cancer patients using imaging techniques

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of a combined imaging assessment system using ultrasound and abdominal CT/MRI to diagnose and monitor sarcopenia in lung cancer patients. It focuses on understanding the relationship between sarcopenia and lung cancer prognosis, particularly during the perioperative period. By identifying sarcopenia early, the study seeks to improve patient outcomes through timely nutritional support and interventions. The research will also explore the long-term prognosis of lung cancer patients with sarcopenia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Hospitalized patients scheduled for radical resection of lung cancer.
2. With a CT/MRI examination within 1 week.
3. The compliance of examination was good.

Exclusion Criteria:

1. Amputated arm or leg.
2. Severe oedema (oedema higher than knee level).
3. Implantable pacemaker.
4. Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.

Where it's running

• Xinyi Tang
  Chengdu, Sichuan, China Recruiting

Study contacts

• Principal investigator: Xinyi Tang — Department of Medical Ultrasound, West China Hospital, Sichuan University
• Study coordinator: Xinyi Tang, Dr.
• Email: tangxinyi1996@outlook.com
• Phone: +8615680819215

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using ultrasound and AI to diagnose sarcopenia in older adults

  This study is testing if using ultrasound and artificial intelligence can help doctors better diagnose muscle loss in older adults to improve their health and quality of life.

  Recruiting West China Hospital · Chengdu, Sichuan · NCT06199856

• Evaluating body composition's impact on chemotherapy toxicity in lung cancer patients

  This study is testing how body composition affects the side effects of chemotherapy in patients with advanced lung cancer to help improve their treatment experience.

  Recruiting Instituto Nacional de Cancerologia de Mexico · Mexico City · NCT02734069

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• Ultrasound-guided nasal bone fracture reduction

  This study tests whether using ultrasound to guide nasal bone fracture reduction can improve accuracy and outcomes for people with recent nasal injuries.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 1 other locations · NCT07869563

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.